NOTICE OF UPGRADE

Our websites will be unavailable between the hours of AEST 4AM September 17, 2022 and AEST 11PM on date September 18, 2022

InvestoGain Australia
 

SEARCH LISTED COMPANY


Any AUS or NZ company

Browse Australian listed companies

0-9A B C D E F G H I J K L M N O P Q R S T U V W XY Z

Browse current Australian managed funds

0-9A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

SEARCH PRIVATE COMPANY


SEARCH FUNDS

Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:

RACE ONCOLOGY LTD (RAC)

Click here for free access to this company's:
ASX, Legal & CGT Status

Former (or subsequent) names

 

Shareholder links

Our website ranking of RAC: rating 3
(3 out of 5)
COMPANY WEBSITE:

 

REGISTRY:

Automic Group
Level 5, 191 ST GEORGES TERRACE PERTH WA 6000
Tel : +61 (2) 8072 1400 or 1300 288 664 (within Australia)
RegistryWebsite RegistryEmail

Company details

ISIN: AU000000RAC3
Address: Level 36, Gateway 1 Macquarie Place SYDNEY NSW 2000
Tel:  + 61 2 8051 3043

Date first listed: 13/07/2016

Sector: Pharmaceuticals & Biotechnology 
Activities: Historically Mining On 11 April 2016 the company entered into a Heads of Agreement to acquire the Intellectual Property Of Update Pharma, Inc. (a company incorporated in the State of Nevada) pertaining to the oncology drug, Bisantrene

News & Events

Expand this box to read and print

listed entity carried for record purposes only

13/07/2016

 

Click here for free access to this company's:
ASX, Legal & CGT Status

Your comments

Please read our Terms before viewing comments.

 

Company Updates

Post your comments here

Please read our Terms before posting comments.
OMISSIONS
    You can post a comment here about this company

    Please click in the "I'm not a robot" box and enter the word/figures you see in the image that then appears.

    loading Posting your comments. Please wait...

     


     

    Click here for free access to this company's:
    ASX, Legal & CGT Status

    Directors' on-market share transactions (last 5)

    rss feeds

    Purchases Sales

    DATEDIRECTORNUMBERPRICEAMOUNT
    07/02/2023Daniel Tillett6,793$1.920$13,044
    13/01/2023Daniel Tillett25,550$1.966$50,223
    20/12/2022Daniel Tillett46,737$2.123$99,198
    03/11/2022Daniel Tillett4,826$2.311$11,153
    05/10/2022Daniel Tillett23,914$1.874$44,824

    Click here for the last 20 transactions all companies

    Directors & Executives (current)

    NAMETITLEDATE OF APPT
    Mary HarneyNon Exec Chairman08/02/2021
    Brendan BrownCFO01/04/2024
    Phillip LynchNon Exec Director01/06/2020
    Peter SmithExecutive Director29/06/2023
    Peter WebseCompany Secretary

    Date of first appointment, title may have changed.

    Directors & Executives (former)

    NAMETITLEDATE OF APPOINTMENTDATE OF RESIGNATION
    Christina ManfreCFO31/01/202201/04/2024
    Damian Clarke-BruceManaging Director, CEO01/02/202322/08/2023
    John CullityNon Exec Director06/04/201822/08/2023
    Daniel SharpIndependent Director05/12/202229/06/2023
    Daniel TillettCEO17/09/201923/03/2023
    Borje AnderssonExecutive Director01/02/202010/12/2020
    William GarnerNon Exec Director13/07/201628/10/2020
    Chris NtoumenopoulosNon Exec Director13/07/201628/10/2020
    Peter MolloyManaging Director, CEO13/07/201620/05/2020
    Brendan de KauweNon Exec Director13/07/201606/04/2018

    Date of first appointment, title may have changed.